RBF Capital’s Enzo Biochem, Inc. ENZ Stock Holding History

RBF Capital’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-150,000	Closed	-$102K	–	623
2025 Q2	$102K	Sell	150,000 -100,359	-40%	-$32.4K	﹤0.01%	571
2025 Q1	$92.6K	Hold	250,359	–	–	0.01%	549
2024 Q4	$179K	Hold	250,359	–	–	0.01%	508
2024 Q3	$280K	Hold	250,359	–	–	0.01%	515
2024 Q2	$273K	Hold	250,359	–	–	0.02%	492
2024 Q1	$318K	Hold	250,359	–	–	0.02%	459
2023 Q4	$348K	Hold	250,359	–	–	0.02%	439
2023 Q3	$351K	Hold	250,359	–	–	0.02%	403
2023 Q2	$461K	Hold	250,359	–	–	0.03%	373
2023 Q1	$608K	Hold	250,359	–	–	0.04%	314
2022 Q4	$359K	Hold	250,359	–	–	0.03%	388
2022 Q3	$559K	Hold	250,359	–	–	0.05%	317
2022 Q2	$643K	Hold	250,359	–	–	0.04%	309
2022 Q1	$730K	Hold	250,359	–	–	0.05%	318
2021 Q4	$804K	Hold	250,359	–	–	0.05%	304
2021 Q3	$886K	Sell	250,359 -13,553	-5%	-$45.2K	0.05%	283
2021 Q2	$837K	Buy	+263,912	New	+$830K	0.05%	296

RBF Capital's ENZ Position: Q3 2025 in Review

RBF Capital sold out of Enzo Biochem, Inc. (ENZ) in Q3 2025, closing a stake of 150,000 shares — an estimated $102K sold.

RBF Capital first reported a position in ENZ in Q2 2021 and held it in 17 quarters. The position peaked at $886K in Q3 2021. 0 funds tracked by Wall St. Rank hold ENZ as of Q3 2025.

RBF Capital reported no remaining Enzo Biochem, Inc. position as of Q3 2025 after selling out during the quarter.
RBF Capital sold 150,000 Enzo Biochem, Inc. shares in Q3 2025, an estimated $102K.
RBF Capital first reported a position in Enzo Biochem, Inc. in Q2 2021 and held it in 17 quarters.
RBF Capital's Enzo Biochem, Inc. position peaked at $886K in Q3 2021.
0 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2025.

Based on RBF Capital's 13F filing for Q3 2025, filed 14 Nov 2025.